CLINICAL_TRIALS
trial_result
· 2018-07-05
Clinical Trial Update: Treadmill Cardiovascular Safety Study of Erenumab (AMG 334) [Phase 2]
Summary
Phase 2 treadmill cardiovascular safety study of erenumab (AMG 334) completed in patients with stable angina; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Stable Angina | Phase 2 | Status: COMPLETED | Results posted: 2018-07-05